NeuBase Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2015 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
NeuBase Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2015 to 2022.
  • NeuBase Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2023 was -$292K, a 157% decline year-over-year.
  • NeuBase Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2023 was -$240K, a 108% decline year-over-year.
  • NeuBase Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.9M, a 21.6% decline from 2021.
  • NeuBase Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $3.7M, a 28.8% decline from 2020.
  • NeuBase Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $5.19M, a 42% decline from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $2.9M -$799K -21.6% Oct 1, 2021 Sep 30, 2022 10-K 2022-12-21
2021 $3.7M -$1.5M -28.8% Oct 1, 2020 Sep 30, 2021 10-K 2022-12-21
2020 $5.19M -$3.76M -42% Oct 1, 2019 Sep 30, 2020 10-K 2021-12-23
2019 $8.96M Oct 1, 2018 Sep 30, 2019 10-K 2020-12-23
2015 $317K Jan 1, 2015 Dec 31, 2015 10-Q 2016-02-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.